Sol-Gel Technologies
- Business Wire
Sol-Gel Technologies and Galderma Announce Exclusive Licenses for the Commercialization of EPSOLAY® and TWYNEO® in the United States
– Upfront and approval payments of up to $15 million – Tiered royalties ranging from mid- to high-teen percentage of…
Read More »